Capital Advisors Ltd’s Oncorus, Inc. ONCR Stock Holding History

Capital Advisors Ltd’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-121	Closed	–	–	1629
2022 Q2	$0	Buy	121 +54	+81%	+$73	﹤0.01%	1430
2022 Q1	$0	Buy	+67	New	+$188	﹤0.01%	1298

Other funds holding ONCR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Advisors Ltd's ONCR Position: Q3 2022 in Review

Capital Advisors Ltd sold out of Oncorus, Inc. (ONCR) in Q3 2022, closing a stake of 121 shares.

Capital Advisors Ltd first reported a position in ONCR in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 40 funds tracked by Wall St. Rank hold ONCR as of Q3 2022.

Capital Advisors Ltd reported no remaining Oncorus, Inc. position as of Q3 2022 after selling out during the quarter.
Capital Advisors Ltd sold 121 Oncorus, Inc. shares in Q3 2022.
Capital Advisors Ltd first reported a position in Oncorus, Inc. in Q1 2022 and held it in 2 quarters.
Capital Advisors Ltd's Oncorus, Inc. position peaked at $0 in Q2 2022.
40 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.